February 24–26, 2025
Start your plan now to connect with Apexus, HRSA’s 340B Prime Vendor, at the upcoming 340B Coalition Winter Conference to gain new insights for your 340B program. Take this opportunity to learn from our 340B PVP subject matter experts to help increase 340B compliance and streamline operations at your facility.
Education
Get hands-on practical education and technical assistance to help with 340B Program implementation at the upcoming 340B University in San Diego on Sunday, February 23. Learn about 340B compliance from HRSA’s Prime Vendor. Continuing education activity for 7.00 contact hours (0.7 CEUs) is provided. Breakfast and lunch are included.
This is a free event provided by the Prime Vendor for all 340B stakeholders and features a broad range of topics, including:
Presentations
Wednesday, February 26
8:30–9:00 a.m.
Be sure to attend the 340B Prime Vendor Program Update, presented by Shelly Wiest, PharmD, BCPS, FASHP, Apexus Senior Vice President, 340B Compliance and Communications, at the plenary session Wednesday morning. Learn how PVP resources can help your facility and support the value of 340B participation.
Shelly Wiest, PharmD, BCPS, FASHP
Senior Vice President, 340B Compliance and Communications
Apexus
Wednesday, February 26
10:45 a.m.–12:00 p.m.
Track 2
Join Jangus Whitner, Director, 340B Compliance, as he shares insights, best practices, and challenges to maintain patient access.
Panelist
Jangus Whitner, PharmD, MHA, DASPL, 340B ACE
Director, 340B Compliance
Apexus
Online or in person, curricula are available at no cost to support program integrity.
Overview of upcoming live and online events with dates and locations along with information and registration links.
The Prime Vendor Program supports the HRSA 340B Drug Pricing Program as a voluntary program for covered entities and manufacturers.
Frequently asked questions (FAQs) provided by HRSA to address common 340B Program compliance questions.
The 340B Prime Vendor Program partners with suppliers; together they support 340B covered entities’ needs to deliver quality, cost-effective care for our nation’s safety-net providers.
Supports the integrity and transparency of the 340B Drug Pricing Program by providing a standardized and comprehensive approach for manufacturers and covered entities to efficiently resolve overcharges.
The most common reason is that your organization’s email system is blocking messages from us. Follow these whitelist instructions.
The 340B PVP nationwide distribution network facilitates covered entity product access and compliance.